celltrion vegzelma permission canada
Scope
Date
~
-
Airlines
Air Premia, Alaska Airlines sign interline agreement
South Korea's Air Premia Inc. announced on Thursday that it partnered with Alaska Airlines, the fifth-largest US carrier, through an interline agr...
14 HOURS AGO
-
Korean startups
Korea’s No. 1 flea market app Karrot expands services across Canada
Danggeun Market Inc., South Korea’s largest online flea market service provider, is expanding its online used-goods marketplace app Karrot acr...
17 HOURS AGO
-
Banking & Finance
Shinhan Card, Canada's Alberta to co-work for tourism
South Korea's Shinhan Card Co. announced on Wednesday that it signed a strategic business agreement with the provincial government of Alberta, C...
Jun 12, 2024 (Gmt+09:00)
-
Shipping & Shipbuilding
Hanwha Ocean, Canadian firms to collaborate on submarine projects
South Korea's Hanwha Ocean Co. announced on Friday that it partnered with three Canadian companies at Canada’s largest defense exhibition, CAN...
May 31, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion eyes M&A in Europe, $3.3 bn Zymfentra sales: chairman
WASHINGTON, D.C. – South Korean biosimilar giant Celltrion Inc. is accelerating its push to transform into a novel drug developer, going after...
May 23, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to supply Remsima, Herzuma to Peru
South Korea's Celltrion Inc. announced on Thursday that it secured a contract to supply its biosimilars for autoimmune disease treatment and antican...
May 02, 2024 (Gmt+09:00)
-
Batteries
Honda, POSCO Future M to build cell materials plant in Canada
Japan’s Honda Motor Co. and South Korea’s POSCO Future M Co. agreed to build a battery materials plant in Canada where the automaker wil...
Apr 26, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion releases Remsima SC in Denmark
South Korea's Celltrion Inc. announced on Thursday that it released its autoimmune disease treatment Remsima SC (infliximab) in Denmark. Remsima SC ...
Apr 19, 2024 (Gmt+09:00)
-
Batteries
POSCO Holdings, KNOC to jointly secure lithium in Canada
POSCO N.EX.T Hub, the venture platform of POSCO Holdings Inc., announced on Thursday that it signed a memorandum of understanding (MOU) with the K...
Apr 18, 2024 (Gmt+09:00)
-
Bio & Pharma
Korea’s Celltrion, SK Biopharmaceuticals benefit from direct US sales
Celltrion Inc. and SK Biopharmaceuticals Co. are witnessing improving sales revenue and profitability by selling their products through their own ma...
Apr 16, 2024 (Gmt+09:00)
-
Aerospace & Defense
Korea’s HD Hyundai ties up with GE, L3Harris for warship exports
South Korea’s top shipbuilder HD Hyundai Heavy Industries Co. is joining hands with major US defense technology firms to expand its presence i...
Apr 11, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion'a autoimmune disease drug Zymfentra makes US debut
South Korean biopharmaceutical giant Celltrion Inc. said on March 17 that it has launched its new autoimmune disease treatment Zymfentra in the US m...
Mar 18, 2024 (Gmt+09:00)
-
Banking & Finance
Mirae Asset rebrands Canadian subsidiary to Global X
South Korea's Mirae Asset Global Investments Co. announced on Thursday that it will change the name of its Canadian exchange-traded fund (ETF) manag...
Mar 07, 2024 (Gmt+09:00)
-
Logistics
Hyundai Movex to supply smart logistics for EcoPro BM Canada plant
South Korea’s Hyundai Movex Co., the logistics automation solutions affiliate of Hyundai Group, announced on Wednesday that it signed a 20 bil...
Mar 06, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion ships initial supply of Zymfentra to US
South Korea's Celltrion Inc. announced on Wednesday that it shipped the first supply of its subcutaneous injection type of the autoimmune disease tr...
Feb 29, 2024 (Gmt+09:00)
-
Automobiles
Genesis G80, GV70 electric models win Canada Car of the Year awards
Hyundai Motor Co. 's premium brand Genesis announced on Friday that its Electrified G80 and Electrified GV70 earned prizes at the 2024 Canadian Ca...
Feb 16, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to deliver three treatments to Peru
South Korea’s Celltrion Inc. announced on Thursday that it will supply three treatments, including its blood cancer drug Truxima (rituximab) t...
Feb 15, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to supply Remsima SC, Yuflyma to Norway
South Korea's Celltrion Inc. announced on Wednesday that it will supply its autoimmune disease treatments Remsima SC (infliximab) and Yuflyma, the...
Feb 07, 2024 (Gmt+09:00)
-
Business & Politics
Korean mining company to file around $747 mn claim against Panama
A state-run company in South Korea is set to seek an investor-state dispute settlement (ISDS) worth around 1 trillion won ($747.1 million) against t...
Jan 25, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion, WuXi XDC to develop new antibody-drug conjugates
South Korea’s Celltrion Inc. has signed a business agreement with China’s WuXi XDC to jointly develop new antibody-drug conjugates (ADC)...
Jan 24, 2024 (Gmt+09:00)
-
Food & Beverage
Lotte Wellfood enters Costco stores in Canada, Mexico
South Korea's Lotte Wellfood Co. announced on Tuesday that it is expanding exports to Mexico and Canada through Costco. It marks the first entry o...
Jan 23, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to export three anticancer drugs to Europe
South Korea’s Celltrion Inc. announced on Thursday that it has secured supply contracts for three anticancer biosimilars in European countries...
Jan 18, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion Holdings eyes Nasdaq IPO by early 2025: chairman
South Korean biosimilar giant Celltrion Group is planning to debut on the Nasdaq market by early 2025, founder and Chairman Seo Jung-jin said at the...
Jan 16, 2024 (Gmt+09:00)
-
Batteries
Samsung SDI to invest in Canada Nickel, new mine in Canada
Samsung SDI Co. has agreed to invest $18.5 million in Canada Nickel Company Inc. to secure steady supplies of nickel and cobalt, key materials for r...
Jan 15, 2024 (Gmt+09:00)
-
Cryptocurrencies
Foreign-listed bitcoin ETF trading suspended in S.Korea
South Korean investors’ years-long trading of spot-bitcoin exchange-traded funds (ETFs) listed in Canada and Germany was abruptly suspended du...
Jan 12, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to expand Yuflyma supply network in Europe
South Korea’s Celltrion Inc. announced on Friday that it will supply its biosimilar Yuflyma (active ingredient: adalimumab) for the treatment ...
Jan 12, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion revises up earnings goals to overtake Amgen
Celltrion Inc., South Korea's leading biosimilar maker, on Wednesday expressed its ambition to join the global top 10 biotech and pharmaceutical com...
Jan 11, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for interchangeability of Yuflyma in US
South Korea's Celltrion Inc. announced on Wednesday that it has applied to the US Food and Drug Administration (FDA) for a modified approval to repl...
Jan 10, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Celltrion to sell portfolio of Takeda drugs to CBC Group
South Korea’s Celltrion Inc. will divest of a portfolio of Takeda Pharmaceutical's prescription medicines sold in Asia to CBC Group, a Singapo...
Jan 01, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for approval of Xolair biosimilar in Canada
South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has applied for CT-P39, a biosimilar of the treatment of asth...
Dec 27, 2023 (Gmt+09:00)